rs201266825
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1
The NM_004370.6(COL12A1):c.1896C>T(p.Tyr632Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,497,786 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00017 ( 1 hom. )
Consequence
COL12A1
NM_004370.6 synonymous
NM_004370.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00
Publications
0 publications found
Genes affected
COL12A1 (HGNC:2188): (collagen type XII alpha 1 chain) This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
COL12A1 Gene-Disease associations (from GenCC):
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp
- Ullrich congenital muscular dystrophy 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 6-75181207-G-A is Benign according to our data. Variant chr6-75181207-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 542518.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00148 (110/74240) while in subpopulation AFR AF = 0.00436 (92/21110). AF 95% confidence interval is 0.00364. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL12A1 | NM_004370.6 | c.1896C>T | p.Tyr632Tyr | synonymous_variant | Exon 11 of 66 | ENST00000322507.13 | NP_004361.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL12A1 | ENST00000322507.13 | c.1896C>T | p.Tyr632Tyr | synonymous_variant | Exon 11 of 66 | 1 | NM_004370.6 | ENSP00000325146.8 |
Frequencies
GnomAD3 genomes AF: 0.00147 AC: 109AN: 74140Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
109
AN:
74140
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000250 AC: 48AN: 191852 AF XY: 0.000245 show subpopulations
GnomAD2 exomes
AF:
AC:
48
AN:
191852
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000165 AC: 235AN: 1423546Hom.: 1 Cov.: 31 AF XY: 0.000146 AC XY: 103AN XY: 707262 show subpopulations
GnomAD4 exome
AF:
AC:
235
AN:
1423546
Hom.:
Cov.:
31
AF XY:
AC XY:
103
AN XY:
707262
show subpopulations
African (AFR)
AF:
AC:
85
AN:
31426
American (AMR)
AF:
AC:
8
AN:
37762
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
24844
East Asian (EAS)
AF:
AC:
1
AN:
39318
South Asian (SAS)
AF:
AC:
17
AN:
80504
European-Finnish (FIN)
AF:
AC:
0
AN:
52274
Middle Eastern (MID)
AF:
AC:
1
AN:
5328
European-Non Finnish (NFE)
AF:
AC:
103
AN:
1093464
Other (OTH)
AF:
AC:
19
AN:
58626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00148 AC: 110AN: 74240Hom.: 0 Cov.: 31 AF XY: 0.00156 AC XY: 55AN XY: 35276 show subpopulations
GnomAD4 genome
AF:
AC:
110
AN:
74240
Hom.:
Cov.:
31
AF XY:
AC XY:
55
AN XY:
35276
show subpopulations
African (AFR)
AF:
AC:
92
AN:
21110
American (AMR)
AF:
AC:
12
AN:
5296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1914
East Asian (EAS)
AF:
AC:
0
AN:
2426
South Asian (SAS)
AF:
AC:
1
AN:
1336
European-Finnish (FIN)
AF:
AC:
0
AN:
4038
Middle Eastern (MID)
AF:
AC:
0
AN:
166
European-Non Finnish (NFE)
AF:
AC:
3
AN:
36530
Other (OTH)
AF:
AC:
2
AN:
878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
COL12A1: BP4, BP7 -
Oct 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.